Weekly paclitaxel with and without concurrent radiation therapy: Toxicity, pharmacokinetics, and response

Seminars in Oncology

Volumn 23, Issue 6 SUPPL. 16, 1996, Pages 128-135

  Glantz, M J ^a   Choy, H ^a   Akerley, W ^a   Kearns, C M ^a   Egorin, M J ^a   Rhodes, C H ^a   Cole, B F ^a  

^a MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

ADULT; AGED; ASTROCYTOMA; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG RESPONSE; DRUG SCREENING; ESOPHAGITIS; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; SENSORY NEUROPATHY;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ASTROCYTOMA; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PACLITAXEL; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030460370     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)